Dynamk Capital participates in Life Science Investor Panel during JPMorgan Healthcare Week
San Francisco, CA – January 14, 2020 – RESI Redefining Early Stage Investments Conference 2020 Life Science Tools Panel Discussion
Join panelists from Arch Ventures, Agilent, Dynamk Capital, Nanodimension and others.
While new breakthroughs in treatment make headlines, the tools that help these breakthroughs happen are frequently overlooked. This panel features investors who are focused on these resources that are used to advance the most cutting-edge research done today. Topics may include: - What types of technology are investors seeking? - How do investors evaluate new technologies? - What kinds of validation do investors wish to see? Panelists will discuss the technologies that are changing how new therapies are developed, tools such as organs-on-a-chip, drug discovery platforms, new instrumentation, and data analytics platforms. The panel will cover what new technologies are emerging, what investors are seeking, and what they would like to see developed.